Global market for professional acne medication to reach $5.45 billion by 2030, highlights report by Next Move Strategy Consulting – Yahoo Finance | Region & Cash

Stralligence Consulting LLP d/b/a Next Move strategy consulting

The increase in the prevalence of acne diseases, the increase in environmental pollution and its adverse effects on the skin, and the unhealthy lifestyle of the urban population are driving the global growth of the professional acne medication market.

NEW YORK, July 7, 2022 (GLOBE NEWSWIRE) — According to the report published by Next Move Strategy Consulting, the global professional acne drug market generated US$2.80 billion in 2021 and is expected to reach US$5.45 billion by 2030, at a CAGR of 7.2% from 2022 to 2030. The report provides a detailed analysis of the market dynamics and the leading market players. Additionally, the study analyzes key segments by country and region to outline the performance of each segment and its sub-segments.

With a comprehensive analysis of all aspects of the market in 400 pages using 541 tables and 266 figures, the report helps leading players, start-ups, investors and stakeholders to develop strategies for sustainable growth and a strong foothold in the professional Acne Drugs industry .

Request a free sample:

report coverage


forecast period


base year


Market size in 2021

$2.80 billion

Market size in 2030

$5.45 billion



number of pages






segments covered

Distribution Channel, Acne Type, Therapeutic Class, Formulation and Geography.


Increase in the prevalence of acne diseases

Increase in pollution and its negative effects on the skin

Unhealthy lifestyle of city people


Huge untapped potential in emerging markets

The development of effective drugs with fewer side effects

The study provides a detailed account of the drivers, growth inhibitors and opportunities of the global Acne Treatment Drugs market. According to the report, the increase in the prevalence of acne diseases, the unhealthy lifestyle of the urban population, the increase in environmental pollution and its adverse effects on the skin, and changes in hormone levels are driving the growth of the market. However, the side effects of acne medications, including dry skin, skin irritation and skin redness, are hampering the market growth. The presence of alternative treatments also stunts growth.

Outlining the opportunities playing a critical role in expanding the professional acne medication market, the Lead Analyst for the Life Sciences & Healthcare category at Next Move Strategy Consulting stated, “There is huge untapped potential for skin care medications in the emerging market players can tap into. In addition, the development of effective drugs with fewer side effects opens up new possibilities in the coming years.”

Buy this report right here:

The study provides detailed segmentation of the global acne medication market based on distribution channel, acne type, therapeutic class, formulation and geography. It also provides a detailed analysis of each sub-segment of these segments. Based on distribution channels, the research segments the market into medical spas, dermatologists, beauticians, and other professional channels. On the basis of acne type, the report splits the market into non-inflammatory acne and inflammatory acne.

By therapeutic class, research further classifies the market into retinoids, benzoyl peroxide, salicylic acid, antibiotics, and others. Among these sub-segments, the retinoids segment is further divided into topical retinoid & combined retinoid and oral retinoid (isoretinion). In addition, the Antibiotics segment is divided into topical antibiotics and combination antibiotics and oral antibiotics. On the basis of formulation, the report segments the market into topical medications and oral medications. Such detailed analysis is helpful for market players to take the necessary steps to expand their market share in professional acne medication.

If you need a customized report, contact us here:

Based on region, the report segments the market into North America, Europe, Asia Pacific and RoW. The study also found that North America held the lion’s share of the global professional acne medication market in 2021. This is due to the increasing acceptance of skin care products, rising awareness of new drugs, and the presence of pipeline drugs by leading pharmaceutical companies. However, it is estimated that Asia-Pacific will witness considerable growth over the forecast period. This is attributed to the increasing demand for acne therapeutics, the increase in healthcare spending, and increased awareness of new therapeutics that can replace existing ones.

With a thorough analysis of each region and country based on the above segments and sub-segments, the report aims to assist market players and investors in expanding their businesses and investments in specific segments and regions.

If you have any questions, you can inquire before buying:

The report provides a detailed analysis of the key market players to outline the competitive scenario of the global Acne Drugs Market. It analyzes leading market players including Almirall SA., Johnson & Johnson, Bausch Health Companies, Inc., Sun Pharmaceutical Industries Limited, Galderma SA, GlaxoSmithKline Plc (GSK), Mylan NV, Mayne Pharma Group Limited, Pfizer Inc. and Teva Pharmaceutical Industries ltd The study also discusses the strategies employed by them to gain competitive advantage and make their mark internationally.

Buy a full report here:

Also browse related reports:

Biopharmaceutical Market by product (monoclonal antibody, interferon, insulin, growth and coagulation factor, erythropoietin, vaccine, hormone and others) and by application (oncology, blood disease, metabolic disease, infectious disease, cardiovascular disease, neurological disease, immunology and others) – Global Opportunity Analysis and Industry Forecast 2022-2030

Antibiotics market by type (cephalosporins, penicillins, fluoroquinolones, macrolides, carbapenems, aminoglycosides, sulfonamides), by spectrum (broad spectrum, narrow spectrum), by mechanism (cell wall synthesis inhibitors, protein synthesis inhibitors, DNA synthesis inhibitors, RNA synthesis inhibitors). , Mycolic Acid Inhibitors, Folic Acid Synthesis Inhibitors) by Distribution Channel (Retail Pharmacy, Online Pharmacy, and Hospital Pharmacy) Global Opportunity Analysis and Industry Forecast, 2020-2030

analgesic market by Type (Non-Opioids and Opioids) and by Route of Administration (Oral, Intravenous, Rectal, Transdermal, and Topical) – Global Opportunity Analysis and Industry Forecast 2020-2030

About us:

Next Move Strategy Consulting is a leading market research and management consulting firm committed to providing clients with strategically analyzed, well-documented, cutting-edge research reports. The research industry is awash with many companies to choose from. What sets Next Move apart from the rest is its world-class research and obsession with turning data into knowledge by analyzing every piece of it and providing fact-based research recommendations backed by information gathered from over 500 million websites, paid databases, industry journals, and One-on-one consultations with industry experts from a variety of industries have been collected. The high quality custom research reports with actionable insights and excellent end-to-end customer service help our clients make important business decisions that enable them to go ahead and have a competitive advantage in the industry.

We’ve served over 1,000 clients worldwide for over a decade, including 90% of the Fortune 500 companies. Our analysts constantly follow various high-growth markets and identify hidden opportunities in each sector or industry. We offer one of the industry’s best syndicates as well as custom research reports across 10 different industry verticals. We strive to deliver high quality research solutions in alignment with your business needs. Ranging from pre-consultation to after-sales service, our industry-standard delivery solutions deliver a superior customer experience and ensure the right strategic decision-making for businesses.

CONTACT: Joseph Lawrence Head - Client Engagement & Servicing Next Move Strategy Consulting E-Mail: Direct: +1-217-650-7991 You can also email us at - Website:

Leave a Comment